Most of the knowledge from in vitro ischemic stroke studies is based on monolayer cultures of neural cells. This traditional simplified culture system is of undisputed importance for stroke research, especially given its relatively low cost and reproducibility compared to animal models. However, two-dimensional (2D) cultures cannot mimic the complex microenvironment experienced by cells in tissues. Unlike cells in 2D culture, in the brain, cells are able to generate 3D projections and establish multiple interactions with other cells and cell types as well as the extracellular matrix (ECM), ultimately affecting their morphology, survival and proliferation, differentiation, gene expression, and even function. Therefore, 3D models of the brain are considered to be more realistic models of the human brain than traditional 2D models and can better simulate its complexity and possible ischemia-induced responses.
Fig. 1. Engineering 3D cortical spheroids for an in vitro ischemic stroke model. (Ko et al., 2021)
Ace Therapeutics is committed to developing 3D in vitro models of ischemic stroke. Our team of expert scientists and engineers combine their extensive knowledge and experience to create highly reproducible and customizable 3D models of the cerebral spheroids or organoids.
Cerebral Spheroids | Cerebral Organoid | |
---|---|---|
Cellular Source | Differentiated cells, multicellular mixture, primary cells | Stem cells: embryonic, adult, or pluripotent |
Culture Conditions | Cultures with or without ECM and growth factors, self-assemble on heterogenous sphere format | Require ECM and growth factors, self-assemble with different cell lineages, resembling the structure and function of an organ |
Advantages |
|
|
Ace Therapeutics builds easy-to-execute programs for 3D in vitro ischemic stroke models to help clients with in vitro stroke injury assessment and treatment outcomes. Our 3D in vitro ischemic stroke models complement traditional 2D cell culture and animal studies. Need to know more? Contact us and let one of our experts provide you with all the answers you need.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.